Cartesian Therapeutics (RNAC) EBITDA Margin Growth (1y) (2016 - 2026)
Cartesian Therapeutics (RNAC) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cartesian Therapeutics |
261.84 Mn |
261.84 Mn |
- |
-4.86 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-4.86 Mn |
| Dec 31, 2025 |
564,879.00 |
| Sep 30, 2025 |
-169,242.00 |
| Mar 31, 2025 |
-63,399.00 |
| Dec 31, 2024 |
288,407.00 |
| Sep 30, 2024 |
-611,499.00 |
| Jun 30, 2024 |
25,908.00 |
| Mar 31, 2024 |
-60,809.00 |
| Dec 31, 2023 |
-218,399.00 |
| Sep 30, 2023 |
-9,937.00 |
| Jun 30, 2023 |
-23,965.00 |
| Mar 31, 2023 |
-44,955.00 |
| Dec 31, 2022 |
-594.00 |
| Sep 30, 2022 |
3,491.00 |
| Jun 30, 2022 |
-108.00 |
| Mar 31, 2022 |
30,721.00 |
| Dec 31, 2021 |
16,993.00 |
| Sep 30, 2021 |
13,683.00 |
| Dec 31, 2020 |
9,453.00 |
| Dec 31, 2019 |
140,332.00 |
